Thank you, Dick. Starting on slide five, we highlight our top lines for the quarter and full year periods. Fourth quarter revenue increased 8%, or nearly $10 million to $141 million, excluding the favorable impact of foreign currency exchange rate fluctuations on revenue of $1.6 million organic growth was approximately 6%. Industrial markets were up 23% in the quarter, benefiting from strong end market demand within industrial automation, vehicle handling, and power quality solutions focused on the oil and gas and HVAC markets. Within our vehicle markets, our automotive customers began to ramp up their programs as expected this past year. We also saw a nice demand for power storage, which helped drive the overall vertical up 17% in the quarter. Offsetting some of that growth continued to be lower demand within agricultural vehicles, given the softness in Europe, which was largely influenced by the Ukrainian conflict. A&D sales were down just given the timing and resulting lumpiness around certain defense and space projects, along with customer-driven supply chain challenges within the vertical. Medical market declined due to softness in medical mobility, which has largely reflected a reduction in demand that we experienced during the last two years of those products driven by a specific customer. Slide six provides some details regarding our full year performance and shows the change in our revenue mix and the drivers behind each change. Industrial continues to lead the way and remains our largest market, making up 44% of total 2023 sales. That's an increase of 600 basis points since 2022. The 33% growth in industrial space was driven primarily by the same market as fourth quarter and reflected continued improvements within the supply chain environment, which supported the shipping of some long-lead projects. The A&D vertical is better evaluated on an annual basis given program timing, and for the year we grew to low double digits due to the success of winning new defense projects and the ramping of other programs. We also benefited from positive commercial aircraft demand, given overall improvements within the industry. Vehicle market revenue was up 2% and reflects the same demand drivers as the fourth quarter. Medical sales were nearly flat as we continue to see a return to a more normalized sales environment focused on surgical and instrumentation-related end markets. And lastly, sales for the distribution channel, which are a small component of total sales, were up 6% for the year. As highlighted on slide seven, gross margin expanded 40 basis points for the quarter and full year period on higher volume and favorable mix, along with the continued emphasis and usage of our lean toolkit throughout the organization. These impacts more than offset elevated raw material costs and remaining supply chain inefficiencies. Moving to slide eight for our operating performance, you will notice that we had a sizable increase in business development costs for the quarter and full year period. Those expenses were in support of the recent acquisitions, an increase for our prior acquisition, and an earn out, and some rationalization efforts around our manufacturing footprint to position us to drive stronger operating leverage in the future. On an annual basis, we did gain some operating leverage which drove operating income growth of 34% to $42.3 million, or 7.3% of sales up 100 basis points. On slide nine, we present GAAP net income and adjusted net income, which we believe provides a better understanding of our earnings power, inclusive of adjusting for the non-cash amortization of intangible assets, which reflects the company's strategy to grow through acquisitions as well as organically. Fourth quarter net income increased 18% to $4.3 million, or $0.26 per diluted share, and on an adjusted basis was up 31% to $9.1 million, or $0.55 per diluted share. Included in the fourth quarter results was a tax benefit of $0.4 million, which reflected realization of certain NOLs and R&D credits and incentives. For the full year, net income increased 39% to $24.1 million, or 1.48 for diluted share. On an adjusted basis, the annual net income increased 25% to $37.5 million, or $2.30 for diluted share. The effective tax rate was 18.9% in 2023, which reflected the tax benefit from the fourth quarter due to realization of certain NOLs and R&D credits. This compared with an effective tax rate of 26.6% during 2022. We expect our income tax rates for the full year 2024 to be approximately 21% to 23%. We use adjusted EBITDA as an internal metric and believe it is useful in determining our progress and operating performance. Adjusted EBITDA increased 2% to $16.9 million, or 12% of revenue. For the year, adjusted EBITDA increased 18% to $77.2 million, or 13.3% of revenue, which was up 30 basis points. Slides 10 and 11 provide an overview of our cash flow and balance sheet. We generated $45 million of cash from operations for the year, which represented a record level for the company and a significant increase from the $5.6 million generated during the prior year period. The increase reflected higher net income and improved working capital management. Based on our cash flow projections, we expect to continue to drive strong cash flows consistent with historical trends. Annual capital expenditures were $11.6 million and largely focused on new customer projects. We expect 2024 capital expenditures to increase from this level, being the range of $16 million to $20 million. Inventory turns improved to 3.0 times compared with under three times last year. Our DSO was slightly elevated at 56 days for the year, largely reflecting timing and mix of customers. Total debt was approximately $218 million, down $17.1 million from year-end 2022. Debt net of cash was about $187 million, or 42.6% of net debt to capitalization. Our bank leverage ratio was 2.8 times. Lastly, we recently extended the maturity of our existing [ph] $280 million revolving credit facility for [Audio Gap] 2029. Borrowings for the revolving facility will bear interest on the sliding-scale rate based on leverage of 1.25% to 2.5% over SOFR. In addition, for added flexibility, we entered into a $100 million fixed-rate private shelf facility with Prudential. The notes will have a maturity date of no more than 10.5 years after the date of original issuance and may be issued through March, 2027. Currently, there are no borrowings under this agreement. With that, I'll now turn the call back over to Dick.